CA49937-1 - 0x000000000000699B

Males & Females of Non-Childbearing Potential

Morning

* Stipend may pay up to reflected amount.
Start Date: 
January 18, 2026 - 2:00pm
End Date: 
March 30, 2026 - 9:30am

Study Details

Study Number: CA49937
Group Number: 1
Study Requirement: Healthy Normal Male and Female
Stipend: up to $7,000.00

Study Criteria

Age: 19 - 55
BMI: 0 - 0
Weight Restriction: minimum weight 0 lbs

Study Information

Indication: This investigational medication is being developed to treat inflammatory bowel disease.
Route of Administration: Injection IV infusion; Injection subcutaneous
Blood Draws: 16

Study Schedule

Schedule Type: Short stays with returns
Study Length: 5 Night Stay & 5 Returns

Screening Dates:

Event Day Event Date
Monday 1/12/2026
Friday 1/16/2026
Saturday 1/17/2026

Doctor Exam Dates:

Event Day Event Date
Monday 1/12/2026
Friday 1/16/2026
Saturday 1/17/2026

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Sunday 1/18/2026 2:00:00 PM Friday 1/23/2026 8:30:00 AM 1 Lincoln
Return Wednesday 1/28/2026 7:30:00 AM Wednesday 1/28/2026 8:30:00 AM 1 Lincoln
Return Monday 2/2/2026 7:30:00 AM Monday 2/2/2026 8:30:00 AM 1 Lincoln
Return Monday 2/16/2026 7:30:00 AM Monday 2/16/2026 8:30:00 AM 1 Lincoln
Return Monday 3/2/2026 7:30:00 AM Monday 3/2/2026 8:30:00 AM 1 Lincoln
Return Monday 3/30/2026 8:30:00 AM Monday 3/30/2026 9:30:00 AM 1 Lincoln